NH Okinawa Fenwal Amicus Apheresis reagents and consumables

The contract is an award notice from the Defense Health Agency (DHA), part of the U.S. Department of Defense, for the acquisition of Fenwal Amicus Apheresis reagents and consumables. The award, valued at $48,356.27, was granted to Fenwal, Inc., a company based in Lake Zurich, Illinois. The primary objective of the contract is to support apheresis medical procedures at NH Okinawa, located in Okinawa, Japan, by supplying the necessary reagents and consumables essential for blood component collection and processing. Awarded on August 19, 2025, under solicitation number HT941025PE004, this contract does not include any set-aside for small businesses or other groups. The procurement falls under NAICS code 325413, which covers manufacturers of in-vitro diagnostic substances, and is classified under code 6515 for medical and surgical instruments. The main points of contact for this contract are Cha-On Gordon and Tracy Robinson, whose roles are to handle contract-related communications. The place of performance is specified as Okinawa, Japan, with the administrative office based in Falls Church, Virginia, USA. The contract remains active and supports U.S. military healthcare operations abroad.